Single center distribution of candida species

IRYO - Japanese Journal of National Medical Services

Volumn 65, Issue 3, 2011, Pages 167-171

  Shimonaka, Akiko ^a   Morii, Daiichi ^a   Tadera, Kayoko ^a   Shimohana, Junichi ^a   Michinaka, Toshie ^a   Tatushima, Junji ^a   Taniyama, Ki Yomi ^a,b  

^a Department of Clinical Laboratory ^*  (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Candida glabrata; Candidemia; Colonization; Fungus disease

Indexed keywords

EID: 79955544689     PISSN: 00211699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999:29: 1164-70. (Pubitemid 30265634)
2. Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002:40: 3551-7.
3. Drago M, Scaltrito MM, Morace G, et al. In vitro activity of voriconazole and oter antifungal agents against clinical isolates of Candida glabrata and Candida krusei. Eur J Clin Microbiol Infect Dis 2002:23: 619-24.
4. Spellberg BJ, Filler SG, Edwards JE Jr, et al. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 2006:42: 244-51. (Pubitemid 43054198)
5. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NE-MIS): veriations in rates of bloodstream infections due to Candida species in seven surgical intensive care units. Clin Infect Dis 1999;29:253-8. (Pubitemid 29380179)
6. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004:42: 1519-27. (Pubitemid 38500790)
7. Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology of candidemia: 3-year result from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002;40:1298-302. (Pubitemid 34279892)
8. Pfaller MA, Diekema DJ, Jones RN, et al. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002:40: 852-6. (Pubitemid 34208634)
9. Piarroux R, Grenouillet F, Balvay P, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004:32: 2552-3.
10. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006:43: 25-31. (Pubitemid 43939072)
11. Delisle MS, Williamson DR, Perreault MM, et al. The Clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care. 2008:23: 11-7. (Pubitemid 351400358)